Up-regulated serum levels of interleukin (IL)-17A and IL-22 in Egyptian pediatric patients with COVID-19 and MIS-C: Relation to the disease outcome

Prediction of COVID-19 severity using laboratory findings on admission: informative values, thresholds, ML model performance

(2021) Yauhen Statsenko et al.   BMJ Open

Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review

(2021) Benjamin M. Liu et al.   CYTOKINE

Interleukin-17A (IL-17A): A silent amplifier of COVID-19

(2021) Francesco Maione et al.   BIOMEDICINE & PHARMACOTHERAPY

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

(2020) Zhe Xu et al.   Lancet Respiratory Medicine

COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

(2020) Tomasz J Guzik et al.   CARDIOVASCULAR RESEARCH

Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients

(2020) Hong-Yi Zheng et al.   Cellular & Molecular Immunology

High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients

(2020) Wenjing Wang et al.   Cellular & Molecular Immunology

COVID-19 outcomes and the human genome

(2020) Michael F. Murray et al.   GENETICS IN MEDICINE

COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome

(2020) Toshio Hirano et al.   IMMUNITY

Association of inflammatory markers with the severity of COVID-19: a meta-analysis

(2020) Furong Zeng et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib

(2020) Dandan Wu et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients

(2020) Yaguang Zhang et al.   Cellular & Molecular Immunology

Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19

(2020) Fang Liu et al.   JOURNAL OF CLINICAL VIROLOGY

Cytokine storm and leukocyte changes in mild versus severe SARS‐CoV‐2 infection: Review of 3939 COVID‐19 patients in China and emerging pathogenesis and therapy concepts

(2020) Jin Wang et al.   JOURNAL OF LEUKOCYTE BIOLOGY

May IL-17 have a role in COVID-19 infection?

(2020) Matteo Megna et al.   MEDICAL HYPOTHESES

Serum interleukin 17A and interleukin 17F in children with inflammatory bowel disease

(2020) Paulina Krawiec et al.   Scientific Reports

Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers

(2020) Youley Tjendra et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Cytokine profile and disease severity in patients with COVID-19

(2020) Ali Ghazavi et al.   CYTOKINE

T cell immunobiology and cytokine storm of COVID‐19

(2020) Xiao‐Hua Luo et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis

(2020) Timotius Ivan Hariyanto et al.   AMERICAN JOURNAL OF EMERGENCY MEDICINE

The IL-17 Family of Cytokines in Health and Disease

(2019) Mandy J. McGeachy et al.   IMMUNITY

Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications

(2017) Leticia Monin et al.   Cold Spring Harbor Perspectives in Biology

Interleukin-17A Is Associated With Alveolar Inflammation and Poor Outcomes in Acute Respiratory Distress Syndrome

(2016) Carmen Mikacenic et al.   CRITICAL CARE MEDICINE

Cytokines IL-17 and IL-22 in the host response to infection

(2016) Maria Valeri et al.   Pathogens and Disease

Interleukin-22: Immunobiology and Pathology

(2015) Jarrod A. Dudakov et al.   Annual Review of Immunology

Interleukin-6 (IL-6) and IL-17 Synergistically Promote Viral Persistence by Inhibiting Cellular Apoptosis and Cytotoxic T Cell Function

(2014) W. Hou et al.   JOURNAL OF VIROLOGY

Interleukin-22 Reduces Lung Inflammation during Influenza A Virus Infection and Protects against Secondary Bacterial Infection

(2013) S. Ivanov et al.   JOURNAL OF VIROLOGY

IL-17 response mediates acute lung injury induced by the 2009 Pandemic Influenza A (H1N1) Virus

(2011) Chenggang Li et al.   CELL RESEARCH

IL-17 and IL-22: siblings, not twins

(2010) Stefanie Eyerich et al.   TRENDS IN IMMUNOLOGY

Critical Role of IL-17RA in Immunopathology of Influenza Infection

(2009) C. R. Crowe et al.   JOURNAL OF IMMUNOLOGY